Gomberg-Maitland M - Search Results

1

New trial designs and potential therapies for pulmonary artery hypertension.

Gomberg-Maitland M, Bull TM, Saggar R, Barst RJ, Elgazayerly A, Fleming TR, Grimminger F, Rainisio M, Stewart DJ, Stockbridge N, Ventura C, Ghofrani AH, Rubin LJ. Gomberg-Maitland M, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D82-91. doi: 10.1016/j.jacc.2013.10.026. J Am Coll Cardiol. 2013. PMID: 24355645 Free PMC article. Review.

2

Prostacyclin therapy for pulmonary arterial hypertension: new directions.

Gomberg-Maitland M, Preston IR. Gomberg-Maitland M, et al. Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. doi: 10.1055/s-2005-916154. Semin Respir Crit Care Med. 2005. PMID: 16121316 Review.

3

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ. Gomberg-Maitland M, et al. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. doi: 10.1164/rccm.200505-766OC. Epub 2005 Sep 8. Am J Respir Crit Care Med. 2005. PMID: 16151039 Clinical Trial.

4

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.

Gomberg-Maitland M, McLaughlin V, Gulati M, Rich S. Gomberg-Maitland M, et al. Am J Cardiol. 2005 Nov 1;96(9):1334-6. doi: 10.1016/j.amjcard.2005.06.083. Epub 2005 Sep 16. Am J Cardiol. 2005. PMID: 16253609 Clinical Trial.

5

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, Barst RJ. Tapson VF, et al. Chest. 2006 Mar;129(3):683-8. doi: 10.1378/chest.129.3.683. Chest. 2006. PMID: 16537868 Clinical Trial.

6

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.

Tapson VF, McLaughlin VV, Gomberg-Maitland M, Widlitz AC, Krichman AD, Laliberte KJ, Zaccardelli DS, Barst RJ. Tapson VF, et al. J Vasc Access. 2006 Jul-Sep;7(3):112-7. doi: 10.1177/112972980600700304. J Vasc Access. 2006. PMID: 17019662 Clinical Trial.

7

Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?

Jacobs A, Preston IR, Gomberg-Maitland M. Jacobs A, et al. Curr Med Res Opin. 2006 Dec;22(12):2567-74. doi: 10.1185/030079906X158020. Curr Med Res Opin. 2006. PMID: 17166339 Review.

8

Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.

Gomberg-Maitland M, Huo D, Benza RL, McLaughlin VV, Tapson VF, Barst RJ. Gomberg-Maitland M, et al. J Heart Lung Transplant. 2007 Jul;26(7):732-8. doi: 10.1016/j.healun.2007.04.013. Epub 2007 Jun 13. J Heart Lung Transplant. 2007. PMID: 17613405 Clinical Trial.

9

Prostacyclin therapies for the treatment of pulmonary arterial hypertension.

Gomberg-Maitland M, Olschewski H. Gomberg-Maitland M, et al. Eur Respir J. 2008 Apr;31(4):891-901. doi: 10.1183/09031936.00097107. Eur Respir J. 2008. PMID: 18378784 Free article. Review.

10

Traditional and alternative designs for pulmonary arterial hypertension trials.

Gomberg-Maitland M. Gomberg-Maitland M. Proc Am Thorac Soc. 2008 Jul 15;5(5):610-6. doi: 10.1513/pats.200803-024SK. Proc Am Thorac Soc. 2008. PMID: 18625753 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters